HIMF-promoted pulmonary hypertension was markedly reduced in HIF-1α (+/−) mice and was driven by the activation of a dysregulated vascular endothelial growth factor receptor 2-A-vascular endothelial growth factor pathway. The gene discussed is HIF1A; the disease is pulmonary hypertension.